HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
OCGN
Ocugen Inc
Healthcare Biotechnology · Pennsylvania, USA · Reports in usd
Market Cap: $518.5M
Market Cap
$518.5M
Enterprise Val
$532.7M
P/E Ratio
-7.64
P/B Ratio
-42.61
Trailing PEG (1Y)
-0.38
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value-$12.2M
Gross Margin100.00%
Profit Margin100.00%
Return on Equity-2,626.38%
Return on Assets-123.83%
Current Ratio1.06
Debt/Equity-2.72
LT Debt/Equity-2.55
Revenue Per Share0.00

Income Statement

Dec 31, 2025
Revenue-$193.0K
Cost of Revenue$0.00
Gross Profit-$193.0K
R&D$10.7M
SG&A$6.1M
Operating Expenses$16.8M
Operating Income-$17.0M
Interest Expense$1.3M
Tax Expense$0.00
Net Income-$17.7M
EPS (Basic)$-0.06
EPS (Diluted)$-0.06
EBIT-$16.4M
EBITDA-$16.4M
Consolidated Income-$17.7M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$18.9M
Accounts Receivable$0.00
Inventory$0.00
Current Assets$24.3M
LT Investments$0.00
Property, Plant & Equipment$14.4M
Intangibles$0.00
Non-Current Assets$19.2M
Total Assets$43.5M
Accounts Payable$6.2M
Current Debt$2.1M
Current Liabilities$23.0M
LT Debt$31.0M
Non-Current Liabilities$32.6M
Total Liabilities$55.7M
Total Debt$33.1M
Retained Earnings-$408.1M
Shareholder Equity-$12.2M
Shares Outstanding312,320,112

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$14.0M
Investing Cash Flow-$35.0K
Financing Cash Flow$2.0K
CapEx-$35.0K
Free Cash Flow-$14.0M
Depreciation & Amort.-$71.0K
Stock-Based Comp$2.0M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid$0.00
Equity Issued/Repaid$2.0K
Dividends Paid$0.00
Net Change in Cash-$14.0M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h